Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1133 issues

How to Get Poteligeo (mogamulizumab-kpkc) Covered by UnitedHealthcare in New York: Prior Authorization, Appeals & Step Therapy Guide

Answer Box: Getting Poteligeo Covered by UnitedHealthcare in New York Poteligeo (mogamulizumab-kpkc) requires prior authorization from UnitedHealthcare for mycosis fungoides or Sézary syndrome treatment. You'll need documented failure of at least one prior systemic therapy and prescribing by a hematologist or oncologist. First step: Gather your CTCL staging
6 min read

How to Get Carbaglu (Carglumic Acid) Covered by UnitedHealthcare in Virginia: Complete PA Guide with Appeals Process

Quick Answer: Getting Carbaglu Covered by UnitedHealthcare in Virginia Yes, you can get Carbaglu (carglumic acid) covered by UnitedHealthcare in Virginia if you have confirmed NAGS deficiency. UnitedHealthcare requires prior authorization with genetic/enzyme testing, elevated ammonia levels, and specialist documentation. If denied, Virginia's external review process via
5 min read

Getting Elfabrio (Pegunigalsidase Alfa-iwxj) Covered by UnitedHealthcare in Ohio: Coding, Prior Authorization, and Appeals Guide

Answer Box: Getting Elfabrio Covered by UnitedHealthcare in Ohio Elfabrio (pegunigalsidase alfa-iwxj) requires prior authorization through UnitedHealthcare/OptumRx for Fabry disease patients in Ohio. Use ICD-10 code E75.21, HCPCS J2508 (1 mg billing units), and 11-digit NDCs. Submit genetic testing or enzyme assay results confirming Fabry disease diagnosis via
6 min read

How to Get Besponsa (Inotuzumab Ozogamicin) Covered by UnitedHealthcare in Virginia: Complete Guide to Prior Authorization, Appeals, and State Protections

Answer Box: Getting Besponsa Covered in Virginia Besponsa (inotuzumab ozogamicin) requires prior authorization from UnitedHealthcare in Virginia. Your oncologist must document CD22-positive B-cell ALL, failed prior chemotherapy, and a hepatic monitoring plan. If denied, Virginia offers strong consumer protections: you can appeal internally (180 days), then request external review through
6 min read

UnitedHealthcare's Coverage Criteria for Mycapssa (Octreotide, Oral) in Illinois: What Counts as "Medically Necessary"?

Answer Box: Getting Mycapssa Covered by UnitedHealthcare in Illinois To get Mycapssa (oral octreotide) approved by UnitedHealthcare in Illinois, you must meet all of these criteria: confirmed acromegaly diagnosis with elevated IGF-1 or GH levels, documented prior response to injectable octreotide or lanreotide, clinical justification for switching to oral therapy,
6 min read